C31G, an equimolar mixture of alkyl dimethyl glycine and alkyl dimethyl amine oxide, was 
Staphylococcus aureus, Streptococcus faecalis, and Escherichia coli when used as a teat dip preparation (1) . Furthermore, it was also effective against Pseudomonas aeruginosa in a mouse burn wound model (7) . Studies have documented the uptake and distribution of oral and topically applied radiolabeled C31G in animals (6) . In addition, no acute toxic effects were observed when C31G was administered to human subjects in a controlled clinical trial under Food and Drug Administration guidelines (V. J. Brightman, A. M. Corner, D. Malamud, J. Slots, and S. L. Yankell, J. Dent. Res. 66:235, 1987) .
To evaluate C31G as a potential agent for use in oral hygiene, we measured its killing activity against a selection of gram-negative and gram-positive bacteria and Candida albicans; we looked at the inhibition of glycolysis by C31G of organisms found in salivary sediment and evaluated its ability to prevent the adherence of strains of Streptococcus sobrinus in vitro. We were particularly interested in activity against cariogenic Streptococcus and Lactobacillus species and activity against periodontal pathogens such as Capnocy-* Corresponding author. tophaga and Actinobacillus species. Other species were chosen due to their potential for pathogenesis.
The combination of antimicrobial and antiadherence activity suggests potential for use in the oral cavity, as an aid to oral hygiene.
MATERIALS AND METHODS
MICs. Serial dilutions of test compounds were made in 10 ml of sterile Trypticase soy broth (TSB), pH 7.3, for species of Staphylococcus, Lactobacillus, Actinomyces, Candida, Escherichia, and Pseudomonas; in 5% sucrose-TSB for Streptococcus species; in brain-heart infusion broth (BHI) for Capnocytophaga species; in BHI supplemented with 0.4% sodium bicarbonate for Actinobacillus species; and in reduced BHI supplemented with 0.5% yeast extract and hemin (5 ,ug/ml)-menadione (0.05 ,ug/ml) solution for Bacteroides species. Bacteria (0.5 ml, 2 x 109 cells) were added to each culture tube and incubated for 20 h at 37°C (C. albicans at 30°C) under aerobic, anaerobic, or microaerophilic conditions as required. The lowest concentration of test compound that inhibited growth was noted.
pH dependence. Previous evidence suggested that C31G had a pH optimum of 5.5 for gram-negative organisms. MICs were set up as described for selected organisms (E. coli, Actinomyces viscosus, and C. albicans) in TSB adjusted with sterile molar citric acid to a range of pHs from 4.5 to 7.0. After incubation at 37°C for 20 h, the lowest concentration inhibiting growth was recorded. In addition, the MIC was determined for species at two pH points, 5.5 and 7.3, in appropriate media adjusted with sterile molar citric acid as before. Again, the lowest concentration of drug inhibiting growth was noted, and comparison was made between the two pHs.
Inhibition of bacterial acid production. Whole saliva, stimulated by chewing unflavored gum base, was collected from donors and pooled. Centrifugation at 800 x g for 15 min gave a sediment which was then concentrated three times by resuspension in 1/3 of the supernatant volume. 0.1%. Following the methods described by Dolan et al. (2), BHI agar-tipped slides coated with this saliva sediment were dipped into test compounds for 1 s and then placed in tubes containing 0.5 ml of 5% glucose. The tubes were incubated at 37°C for the duration of the experiment. After 2 h, slides were removed and pH readings of the glucose solution were taken on an hourly basis for 7 h. The ability of C31G to prevent glucose metabolism by salivary bacteria was determined by the change in pH compared with that of a water control. Inhibition of glycolytic activity in this assay could result from either a bactericidal effect or interference with the bacterial glycolytic process.
Adherence to nichrome wires. C31G was tested for its ability to prevent the adherence of S. sobrinus plaque by a modified method described by Kavanagh et al. (4) . Sterile nichrome wire meshes were exposed to C31G, water, or chlorhexidine gluconate (ICI Pharmaceuticals Ltd., United Kingdom) for 10 s and then placed in 10 ml of 5% sucrosetryptic soy broth inoculated with 1 ml of S. sobrinus (2 x 109 cells). Tubes were incubated at 37°C. After 24, 48, and 72 h, wires were reexposed to test materials, placed in fresh medium, and reinoculated with S. sobrinus. After 96 h, wires were removed from the medium and dried to a constant weight. The amount of adherent plaque for quadruplicate samples was determined by weighing each wire mesh, followed by gentle washing of the wire to remove bacterial deposits. Dry, clean wires were then reweighed, and the mean weight of adherent S. sobrinus was determined by subtraction. Results for test materials were then compared with those obtained for water controls to determine the relative inhibition of adherence.
RESULTS
Preliminary studies have suggested that the susceptibility of gram-negative organisms to C31G is dependent on pH, while gram-positive organisms and yeasts may be less pH dependent. E. coli, A. viscosus, and C. albicans were tested for MIC in media adjusted to a range of pHs from 4.5 to 7.0. Figure 1 shows the effect of pH on the MIC for these three organisms. A. viscosus and C. albicans were equally susceptible to C31G at all pHs tested. E. coli, however, showed a variation in growth inhibition that reached an optimum at pH 5.5.
Clinical Pseudomonas isolates were obtained from Children's Hospital of Philadelphia (courtesy of Thomas Scanlin) The organisms tested for MIC included putative pathogens for both caries (S. sanguis and S. sobrinus) and periodontal disease (Actinobacillus actinomycetemcomitans, Bacteroides intermedius, A. viscosus, and C. sputigena).
To determine whether C31G was effective against the total oral flora present in saliva and not inactivated by salivary proteins, we monitored the effect of C31G on glycolysis in salivary sediment. Figure 2 shows the activity of C31G compared with water and chlorhexidine in the inhibition of bacterial glycolysis. At a concentration of 0.5%, C31G and chlorhexidine totally inhibited bacterial glycolysis for 7 h. Even at a concentration of 0.05%, C31G demonstrated significant inhibition of glycolysis. A comparison with commercial mouthwashes showed that C31G and chlorhexidine were the most effective in inhibiting bacterial glycolysis (Fig.   3) .
To determine the dose-response effect of C31G, concentrations from 0.05 to 2% were tested in a bacterial glycolysis assay (Fig. 4) . There was total inhibition of glycolysis at C31G concentrations ranging from 0.5 to 2% and a graded effect at concentrations of 0.05 to 0.3%.
Since C31G consists of an equimolar mixture of two active compounds, it was of interest to determine the relative antimicrobial effect of each component. As demonstrated in Fig. 5 , the combination of 0.05% alkyl dimethyl glycine and 0.05% alkyl dimethyl amine oxide had much greater inhibitory activity than either of the components alone, demonstrating a synergistic effect.
In terms of potential use as an oral hygiene product, it was important to determine whether C31G maintained its activity 0. when formulated into a mouthwash vehicle. In a vehicle containing alcohol, sorbitol, flavoring, color, and saccharine, 0.5% C31G maintained its antiglycolytic activity after formulation (Fig. 6) . It was also shown that the vehicle alone had no activity.
To be effective as an antiplaque agent, a substance ideally should both be antimicrobial and prevent bacterial adherence. Assessment of C31G in the prevention of bacterial adherence to nichrome wire mesh is shown in Fig. 7 . C31G and chlorhexidine were equally effective in inhibiting bacterial adherence, as shown by the low weight of accumulated S. sobrinus plaque, while the commercial mouthwashes tested were no better than the water control. Lack of S. sobrinus on the nichrome wire mesh could be interpreted as inhibition of adherence or as bactericidal effect. However, at low concentrations of C31G, growth was observed in the culture tubes with no associated adherence of bacteria on the mesh, indicating that C31G was indeed preventing adherence.
DISCUSSION
Successful bacterial colonization of a potential disease site involves both bacterial attachment and proliferation. An ideal antimicrobial agent would inhibit both of these activities. C31G has been demonstrated to manifest broad-spectrum antimicrobial activity, as evidenced by the MICs ob- Preliminary clinical studies under Food and Drug Administration guidelines have begun on C31G as an agent for use in the oral cavity. The diverse properties of C31G suggest that it has applications as an agent to control microbial colonization in potential human and animal infection sites.
